Literature DB >> 29978784

[Methyltransferase-like 3 Promotes the Proliferation of Acute Myeloid Leukemia Cells by Regulating N6-methyladenosine Levels of MYC].

Xiao-Shuang Wang1, Jin-Rong He1, Shan Yu1, Jia Yu1.   

Abstract

Objective To investigate the role of methyltransferase-like 3(METTL3) in the proliferation of acute myeloid leukemia (AML) cells and its mechanism. Methods METTL3 expression in AML patients was analyzed in Gene Expression Omnibus data files. METTL3 expression was inhibited by lentivirus-mediated gene transduction in MOLM13 cells,after which cell proliferation was analyzed by cell counting kit-8,N6-methyladenosine (m6A) levels of total mRNA was analyzed by ELISA,specific m6A on MYC was analyzed by gene-specific m6A RNA immunoprecipitation,and MYC expression was analyzed by RT-qPCR and Western blot analysis. Results METTL3 level was slightly increased in AML-M5 patients,and its expression was significantly higher in immature cells than in mature monocytes (t=4.504,P=0.0098). METTL3 knock-down significantly suppressed cell proliferation (P<0.001),reduced m6A level of total mRNA (t=3.606,P=0.042) and specific m6A level on MYC mRNA (P<0.01),and suppressed MYC expression (P<0.01). Conclusion METTL3 acts as an oncogene in MOLM13 cells by upregulating MYC expression.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29978784     DOI: 10.3881/j.issn.1000-503X.2018.03.002

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  6 in total

Review 1.  The Role of RNA Methyltransferase METTL3 in Normal and Malignant Hematopoiesis.

Authors:  Xia Wu; Wu Ye; Yuping Gong
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

2.  METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia.

Authors:  Zhi-Peng Pan; Bin Wang; Di-Yu Hou; Ruo-Lan You; Xiao-Ting Wang; Wen-Hui Xie; Hui-Fang Huang
Journal:  FEBS Open Bio       Date:  2021-05-20       Impact factor: 2.693

Review 3.  Multiple Functions and Mechanisms Underlying the Role of METTL3 in Human Cancers.

Authors:  Wenhui Zheng; Xiaoshen Dong; Yan Zhao; Shuo Wang; Haiyang Jiang; Mingdi Zhang; Xinyu Zheng; Ming Gu
Journal:  Front Oncol       Date:  2019-12-12       Impact factor: 6.244

4.  m6A RNA modification modulates PI3K/Akt/mTOR signal pathway in Gastrointestinal Cancer.

Authors:  Qijie Zhao; Yueshui Zhao; Wei Hu; Yan Zhang; Xu Wu; Jianwei Lu; Mingxing Li; Wei Li; Weiqing Wu; Jianhong Wang; Fukuan Du; Huijiao Ji; Xiao Yang; Zhenyu Xu; Lin Wan; Qinglian Wen; Xiang Li; Chi Hin Cho; Chang Zou; Jing Shen; Zhangang Xiao
Journal:  Theranostics       Date:  2020-07-25       Impact factor: 11.556

5.  HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.

Authors:  Zhi Yang; Xiaodi Jiang; Deming Li; Xiaofeng Jiang
Journal:  Aging (Albany NY)       Date:  2020-10-13       Impact factor: 5.682

6.  m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis.

Authors:  Fang-Yi Yao; Cui Zhao; Fang-Min Zhong; Ting-Yu Qin; Fang Wen; Mei-Yong Li; Jing Liu; Bo Huang; Xiao-Zhong Wang
Journal:  Front Oncol       Date:  2021-07-20       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.